Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Cash from Operations (2019 - 2026)

Enliven Therapeutics has reported Cash from Operations over the past 8 years, most recently at 19291000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 19291000.0 for Q1 2026, up 20.04% from a year ago — trailing twelve months through Mar 2026 was 65465000.0 (up 11.48% YoY), and the annual figure for FY2025 was 70301000.0, up 3.95%.
  • Cash from Operations reached 19291000.0 in Q1 2026 per ELVN's latest filing, down from 15838000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6447000.0 in Q3 2022 and bottomed at 24127000.0 in Q1 2025.
  • Median Cash from Operations over the past 5 years was 15838000.0 (2025), compared with a mean of 15066470.59.
  • The largest annual shift saw Cash from Operations surged 40.86% in 2022 before it tumbled 146.53% in 2023.
  • Over 5 years, Cash from Operations stood at 8145000.0 in 2022, then plummeted by 53.25% to 12482000.0 in 2023, then plummeted by 37.82% to 17203000.0 in 2024, then increased by 7.93% to 15838000.0 in 2025, then decreased by 21.8% to 19291000.0 in 2026.
  • Business Quant data shows Cash from Operations for ELVN at 19291000.0 in Q1 2026, 15838000.0 in Q4 2025, and 13279000.0 in Q3 2025.